Title: Successful treatment of a patient with acquired haemophilia A with a combination of a low‐dose rituximab and recombinant human <scp>FVII</scp>a
Abstract: HaemophiliaVolume 19, Issue 2 p. e95-e96 Letter to the Editor Successful treatment of a patient with acquired haemophilia A with a combination of a low-dose rituximab and recombinant human FVIIa Y. Xu, Y. Xu The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key laboratory of Thrombosis and Hemostasis, Ministry of Health, Suzhou, Jiangsu Province, People's Republic of ChinaYang Xu and Xuhui Zhang contribute equally to this work.Search for more papers by this authorX. Zhang, X. Zhang The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key laboratory of Thrombosis and Hemostasis, Ministry of Health, Suzhou, Jiangsu Province, People's Republic of ChinaYang Xu and Xuhui Zhang contribute equally to this work.Search for more papers by this authorY. Zhao, Y. Zhao The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key laboratory of Thrombosis and Hemostasis, Ministry of Health, Suzhou, Jiangsu Province, People's Republic of ChinaSearch for more papers by this authorL. Zhao, L. Zhao The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key laboratory of Thrombosis and Hemostasis, Ministry of Health, Suzhou, Jiangsu Province, People's Republic of ChinaSearch for more papers by this authorH. Qiu, Corresponding Author H. Qiu The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key laboratory of Thrombosis and Hemostasis, Ministry of Health, Suzhou, Jiangsu Province, People's Republic of China Correspondence: Huiying Qiu and Depei Wu, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key laboratory of Thrombosis and Hemostasis, Ministry of Health, Suzhou, 215006 Jiangsu Province, China. Tel.: 86 512 67780390; fax: 86 512 65222463; e-mails: [email protected], [email protected]Search for more papers by this authorD. Wu, Corresponding Author D. Wu The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key laboratory of Thrombosis and Hemostasis, Ministry of Health, Suzhou, Jiangsu Province, People's Republic of China Correspondence: Huiying Qiu and Depei Wu, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key laboratory of Thrombosis and Hemostasis, Ministry of Health, Suzhou, 215006 Jiangsu Province, China. Tel.: 86 512 67780390; fax: 86 512 65222463; e-mails: [email protected], [email protected]Search for more papers by this author Y. Xu, Y. Xu The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key laboratory of Thrombosis and Hemostasis, Ministry of Health, Suzhou, Jiangsu Province, People's Republic of ChinaYang Xu and Xuhui Zhang contribute equally to this work.Search for more papers by this authorX. Zhang, X. Zhang The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key laboratory of Thrombosis and Hemostasis, Ministry of Health, Suzhou, Jiangsu Province, People's Republic of ChinaYang Xu and Xuhui Zhang contribute equally to this work.Search for more papers by this authorY. Zhao, Y. Zhao The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key laboratory of Thrombosis and Hemostasis, Ministry of Health, Suzhou, Jiangsu Province, People's Republic of ChinaSearch for more papers by this authorL. Zhao, L. Zhao The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key laboratory of Thrombosis and Hemostasis, Ministry of Health, Suzhou, Jiangsu Province, People's Republic of ChinaSearch for more papers by this authorH. Qiu, Corresponding Author H. Qiu The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key laboratory of Thrombosis and Hemostasis, Ministry of Health, Suzhou, Jiangsu Province, People's Republic of China Correspondence: Huiying Qiu and Depei Wu, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key laboratory of Thrombosis and Hemostasis, Ministry of Health, Suzhou, 215006 Jiangsu Province, China. Tel.: 86 512 67780390; fax: 86 512 65222463; e-mails: [email protected], [email protected]Search for more papers by this authorD. Wu, Corresponding Author D. Wu The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key laboratory of Thrombosis and Hemostasis, Ministry of Health, Suzhou, Jiangsu Province, People's Republic of China Correspondence: Huiying Qiu and Depei Wu, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key laboratory of Thrombosis and Hemostasis, Ministry of Health, Suzhou, 215006 Jiangsu Province, China. Tel.: 86 512 67780390; fax: 86 512 65222463; e-mails: [email protected], [email protected]Search for more papers by this author First published: 12 December 2012 https://doi.org/10.1111/hae.12070Citations: 3 Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Sumner MJ, Geldziler BD, Pedersen M et al. Treatment of acquired haemophilia with recombinant activated FVII: a critical appraisal. Haemophilia 2007; 13: 451–61. 2Garvey B. Rituximab in the treatment of autoimmune haematological disorders. Br J Haematol 2008; 141: 149–69. 3Huth-Kühne A, Baudo F, Collins P et al. International recommendations on the diagnosis and treatment of patients with acquired hemophilia A. Haematologica 2009; 94(): 566–75. 4Collins PW, Hirsch S, Baglin TP et al. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation. Blood, 2007; 109: 1870–7. 5Aggarwal A, Grewal R, Green RJ et al. Rituximab for auto-immune haemophilia: a proposed treatment algorithm. Haemophilia, 2005; 11: 13–9. 6Wermke M, von Bonin M, Gehrisch S et al. Successful eradication of acquired factor-VIII-inhibitor using single low-dose rituximab. Heamatologica 2010; 95: 521–2. Citing Literature Volume19, Issue2March 2013Pages e95-e96 ReferencesRelatedInformation
Publication Year: 2012
Publication Date: 2012-12-12
Language: en
Type: letter
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 11
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot